You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for DIMETHYL FUMARATE DR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DIMETHYL FUMARATE DR

Average Pharmacy Cost for DIMETHYL FUMARATE DR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DIMETHYL FUMARATE DR 240 MG CP 43547-0025-06 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 24979-0128-04 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 31722-0658-32 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 43598-0430-60 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 82009-0138-60 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 16729-0417-12 0.88935 EACH 2025-01-22
DIMETHYL FUMARATE DR 240 MG CP 59651-0084-60 0.88935 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Dimethyl Fumarate Market Analysis and Price Projections

Market Overview

Dimethyl fumarate is a crucial medication, particularly in the treatment of multiple sclerosis and other related conditions. The global market for dimethyl fumarate is poised for significant growth, driven by several key factors.

Drivers of Market Growth

  • Increasing Prevalence of Mental and Physical Health Issues: The rising prevalence of spine and back problems, along with an increase in mental health-related syndromes and diseases, is driving the demand for dimethyl fumarate. This trend is particularly pronounced in regions with advanced healthcare infrastructure and higher public awareness about these conditions[1][4].
  • Advancements in Healthcare and Diagnostic Methods: Early diagnostic methods and the increasing use of effective medicines are contributing to the growth of the dimethyl fumarate market. Strategic collaborations between public and private entities are also boosting R&D activities, leading to breakthrough medications and medical technologies[1][5].
  • Growing Demand for Medications: The pharmaceutical segment is expected to account for the largest revenue share due to the rising demand for medications to treat mental health-related diseases and other conditions. Dimethyl fumarate, particularly under the brand name Tecfidera, is widely used for multiple sclerosis[1][2].

Market Segmentation

By Type

The dimethyl fumarate market is segmented into different purity levels, with dimethyl fumarate 97% and 98% being the primary types. The dimethyl fumarate 97% segment is expected to register the highest revenue share due to its widespread use in common oral medications[1].

By End-Use

The market is segmented into pharmaceutical, food, drink, feed, cosmetic, and other sectors. The pharmaceutical segment dominates the market due to the medication's primary use in treating mental health and multiple sclerosis[1].

By Region

North America is expected to account for the largest revenue share, driven by the high demand for medications, advanced healthcare infrastructure, and increased public awareness about mental health disorders[1][4].

Price Projections and Cost Analysis

Current Pricing

The cost of dimethyl fumarate varies based on the dosage and quantity. For instance, a supply of 60 capsules of 240 mg oral delayed release capsules can range from $337 to $7,605.92, depending on the pharmacy and any discounts applied[2].

Future Pricing Trends

The pricing of dimethyl fumarate is expected to be influenced by several factors, including the cost of production, market demand, and competition from generic versions. As the market grows, there may be a slight decrease in prices due to increased competition and economies of scale in production[1][5].

Challenges and Restraints

  • Lack of Awareness and Infrastructure: In underdeveloped regions, the lack of awareness and inadequate healthcare infrastructure can hamper the market growth of dimethyl fumarate[1].
  • Slow Approval Rates and Patent Expirations: Slow approval rates for new medications and the expiration of patents can also restrain market growth. Additionally, the harmful impacts of existing treatment methods can affect consumer confidence and adoption rates[1].
  • Reimbursement Issues: Unfavorable reimbursement situations in some regions can further limit the market's revenue growth[1].

Revenue Forecasting Techniques

To estimate the market size and revenue of dimethyl fumarate, several techniques are employed:

  • Bottom-Up Approach: This involves estimating the potential market size based on the total population, incidence and prevalence of the disease, addressable market size, and penetration rates[3].
  • Analyst Insights and Research Reports: Cross-checking market estimations with external reports and similar product revenues helps in refining the forecasts[3].
  • Analogue Markets: Analyzing the market performance of similar products can provide valuable insights into the potential market size and revenue of dimethyl fumarate[3].

Market Dynamics and Trends

Growth Drivers

  • Better Efficacy and Safety: Dimethyl fumarate's better efficacy and safety profile compared to existing treatments are key drivers of its market share[3].
  • Synergistic Effects: The medication's synergistic effects with existing treatments also contribute to its market growth[3].
  • Marketing Strategies: Effective marketing, especially in the face of generic competition, is crucial for maintaining market share[3].

Competitive Landscape

The market is characterized by a mix of established and emerging players. Companies are focusing on R&D to develop new formulations and expand their market presence. The report includes detailed profiles of prominent companies, their market entry year, and various market-related factors[5].

Regional Analysis

The global dimethyl fumarate market is segmented into five major regions: North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Each region's revenue share, current trends, and future prospects are analyzed to provide a comprehensive understanding of the market[4].

Key Takeaways

  • The global dimethyl fumarate market is expected to grow steadily, driven by increasing demand for medications and advancements in healthcare.
  • The pharmaceutical segment will dominate the market due to the medication's primary use in treating mental health and multiple sclerosis.
  • North America will account for the largest revenue share due to advanced healthcare infrastructure and high public awareness.
  • Pricing trends will be influenced by production costs, market demand, and competition from generic versions.
  • Challenges include lack of awareness, slow approval rates, and reimbursement issues.

Frequently Asked Questions (FAQs)

1. What is dimethyl fumarate primarily used for?

Dimethyl fumarate is primarily used for the treatment of multiple sclerosis and other related mental health conditions.

2. Which region is expected to dominate the dimethyl fumarate market?

North America is expected to account for the largest revenue share due to advanced healthcare infrastructure and high public awareness about mental health disorders.

3. What are the main challenges facing the dimethyl fumarate market?

The main challenges include lack of awareness and infrastructure in underdeveloped regions, slow approval rates for new medications, patent expirations, and unfavorable reimbursement situations.

4. How is the pricing of dimethyl fumarate expected to evolve?

The pricing is expected to be influenced by production costs, market demand, and competition from generic versions, potentially leading to a slight decrease in prices over time.

5. What techniques are used to estimate the market size and revenue of dimethyl fumarate?

Techniques include the bottom-up approach, analyst insights, research reports, and analysis of analogue markets for similar products.

Sources:

  1. Reports and Data: Dimethyl Fumarate Market Size, Share, Growth, and Forecast 2030.
  2. Drugs.com: Dimethyl Fumarate Prices, Coupons, Copay Cards & Patient Assistance.
  3. iHealthcareAnalyst: Revenue Forecasting Techniques for New Pharmaceutical Drugs.
  4. Cognitive Market Research: Dimethyl Fumarate Market Report 2024 (Global Edition).
  5. Market Research Intellect: Global Dimethyl Fumarate API Market Size, Trends and Projections.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.